Cypherpunk Technologies (NASDAQ:CYPH) Issues Earnings Results

Cypherpunk Technologies (NASDAQ:CYPH) issued its quarterly earnings data on Wednesday. The company reported $0.18 earnings per share for the quarter, FiscalAI reports.

Cypherpunk Technologies Trading Up 2.0%

NASDAQ CYPH traded up $0.01 on Wednesday, hitting $0.69. 409,724 shares of the company were exchanged, compared to its average volume of 3,285,006. Cypherpunk Technologies has a 1-year low of $0.23 and a 1-year high of $3.70. The firm has a 50 day moving average of $0.69 and a two-hundred day moving average of $0.78. The company has a market cap of $73.83 million, a P/E ratio of -34.66 and a beta of 0.09.

Institutional Investors Weigh In On Cypherpunk Technologies

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Acadian Asset Management LLC lifted its position in shares of Cypherpunk Technologies by 470.4% during the first quarter. Acadian Asset Management LLC now owns 1,280,531 shares of the company’s stock worth $389,000 after purchasing an additional 1,056,047 shares in the last quarter. Key Client Fiduciary Advisors LLC acquired a new stake in shares of Cypherpunk Technologies in the fourth quarter valued at approximately $98,000. Sequoia Financial Advisors LLC bought a new position in Cypherpunk Technologies in the 4th quarter worth approximately $56,000. HighTower Advisors LLC bought a new position in Cypherpunk Technologies in the 4th quarter worth approximately $59,000. Finally, Simplify Asset Management Inc. acquired a new position in Cypherpunk Technologies during the 4th quarter worth $2,172,000. Institutional investors and hedge funds own 30.46% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on CYPH. Cantor Fitzgerald upgraded shares of Cypherpunk Technologies to a “strong-buy” rating in a research note on Friday, July 3rd. Weiss Ratings lowered Cypherpunk Technologies from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Friday, July 31st. Finally, Wall Street Zen raised Cypherpunk Technologies from a “sell” rating to a “hold” rating in a report on Saturday, July 4th. One investment analyst has rated the stock with a Strong Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $0.90.

Cypherpunk Technologies Company Profile

Cypherpunk Technologies Inc, previously known as Leap Therapeutics, Inc, is a company developing novel therapies for patients with cancer and implementing a digital asset treasury strategy focused on Zcash. The company’s research platform centers on modulating the tumor microenvironment to enhance anti-tumor immune responses. Cypherpunk’s proprietary pipeline includes DKN-01, a monoclonal antibody designed to neutralize Dickkopf-1 (DKK1), a protein implicated in tumor growth and immune evasion.

DKN-01 is being evaluated both as a monotherapy and in combination with checkpoint inhibitors such as pembrolizumab across multiple solid tumor indications, including gastroesophageal, pancreatic and other advanced malignancies.